血清外泌体miR-20b-5p对非小细胞肺癌的诊断价值

doi:10.6040/j.issn.1671-7554.0.2019.028

摘要/Abstract

摘要： 目的探讨血清外泌体miR-20b-5p对非小细胞肺癌(NSCLC)患者的诊断价值。方法收集144例NSCLC患者(NSCLC组)血清和138例健康对照人群(健康对照组)血清。分离并鉴定血清外泌体。提取血清外泌体miRNA并通过RT-qPCR比较NSCLC组和健康对照组之间miR-20b-5p的表达水平。利用受试者工作特征曲线(ROC)评估miR-20b-5p的诊断价值。结果纯化的外泌体具有已报道的外泌体的典型特征。NSCLC组外泌体miR-20b-5p的表达水平显著高于健康对照组,差异有统计学意义(P<0.001)。ROC曲线下面积(AUC)为0.849(95% CI:0.802~0.889,敏感度为73.61%,特异度为70.29%)。结论血清外泌体miR-20b-5p在NSCLC中高表达,且具有较高的临床诊断价值,可以作为辅助NSCLC诊断的新型生物标志物。

关键词: 血清外泌体, miR-20b-5p, 非小细胞肺癌, 诊断

Abstract: Objective To explore the diagnostic value of serum exosomal miR-20b-5p for non-small cell lung cancer(NSCLC). Methods Serum samples of 144 NSCLC patients(NSCLC group)and 138 healthy controls(healthy group)were collected. Exosomes in the serum were extracted and characterized, and miRNA was abstracted. The expression of exosomal miR-20b-5p in the NSCLC group and healthy control group were compared with RT-qPCR. The diagnostic value of exosomal miR-20b-5p was evaluated with receiver operating characteristic(ROC)curve. Results Purified exosomes had typical features. The expression of miR-20b-5p was significantly higher in the NSCLC group than in the healthy control group (P<0.001). The area under the ROC curve(AUC)was 0.849(95%CI:0.802~0.889). The diagnostic sensitivity was 73.61%, and the specificity was 70.29%. Conclusion Serum exosomal miR-20b-5p is highly expressed in NSCLC with highly clinical diagnostic value. It can serve as a new biomarker to assist the diagnosis of NSCLC.

Key words: Serum exosomal, MiR-20b-5p, Non-small cell lung cancer, Diagnose

中图分类号:

R734.2

魏萍,杜鲁涛,王卿,展垚,谢玉姣,张淑君,段伟丽,王传新. 血清外泌体miR-20b-5p对非小细胞肺癌的诊断价值[J]. 山东大学学报 (医学版), 2019, 57(4): 91-96.

WEI Ping, DU Lutao, WANG Qing, ZHAN Yao, XIE Yujiao, ZHANG Shujun, DUAN Weili, WANG Chuanxin. Diagnostic value of serum exosomal miR-20b-5p for non-small cell lung cancer[J]. Journal of Shandong University (Health Sciences), 2019, 57(4): 91-96.

参考文献

[1] Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin, 2016, 66(4): 271-289.
[2] Doldan X, Fagundez P, Cayota A, et al. Electrochemical sandwich immunosensor for determination of exosomes based on surface marker-mediated signal amplification[J]. Anal Chem, 2016, 88(21): 10466-10473.
[3] Chen X, Liu J, Gu X, et al. Salidroside attenuates glutamate-induced apoptotic cell death in primary cultured hippocampal neurons of rats[J]. Brain Res, 2008, 1238: 189-198. doi: 10.1016/j.brainres.2008.07.051.
[4] Harris DA, Patel SH, Gucek M, et al. Exosomes released from breast cancer carcinomas stimulate cell movement[J]. PLoS One, 2015, 10(3): e117495.doi:10.1371. /journal.pone.0117495.
[5] Lodes M J, Mareelo C, Dominic S, et al. Detection of Cancer with Serum miRNAs on an Oligonueleotide Microarray[J]. PLoS One, 2009, 4(7): 267-275.
[6] Sonia Molina-Pinelo, M. Dolores Pastor, Roc o Suarez et al. MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD[J]. Lung Cancer, 2014, 43(6): 1740-1749.
[7] Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells[J]. Nat Cell Biol, 2007, 9(6): 654-659.
[8] Cazzoli R, Buttitta F, Di Nicola M, etal. MicroRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer[J]. J Thorac Oncol, 2013, 8(9): 1156-1162.
[9] Huang X, Yuan T, Tschannen M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing[J]. BMC Genomics,2013,10(14):319.doi: 10.1186/1471-2164-14-319.
[10] Moreau F, Seyfritz E, Toti F, et al. Early effects of liver regeneration on endocrine pancreas in vivo change in islet morphology and in vitro assessment of systemic effects on beta cell function and viability in the rat model of two-thirds hepatectomy[J]. Horm Metab Res, 2014, 46(13): 921-926.
[11] Simons M, Raposo G. Exosomes-vesicular carriers for intercelluar communication[J]. Curr Opin Cell Biol, 2009, 21(4): 575-581.
[12] Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET[J]. Nat Med, 2012, 18(6): 883-891.
[13] Alegre E, Zubiri L, Perez-Gracia JL, et al. Circulating melanoma exosomes as diagnostic and prognosis biomarkers[J]. Clin Chim Acta, 2016, 15(454): 28-32.
[14] Junker K, Heinzelmann J, Beckham C, et al. Extracellular vesicles and their role in urologic malignancies[J]. Eur Urol, 2016, 70(2): 323-331.
[15] Wang SY, Li Y, Jiang YS, et al. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer[J]. Eur Rev Med Pharmacol Sci, 2017, 21(18):4092-4097.
[16] Mao KP, Zhang WN, Liang XM, et al. MicroRNA-222 expression and its prognostic potential in non-small cell lung cancer[J]. Scientific World Journal, 2014: 908326. doi: 10.1155/2014/908326.
[17] Giallombardo M, Chacartegui Borras J, Castiglia M, et al. Exosomal miRNA analysis in non-small cell lung cancer(NSCLC)patients plasma through qPCR: a feasible liquid biopsy tool[J]. J Vis Exp, 2016, 27(111). doi: 10.3791/53900.
[18] Taverna S, Giallombardo M, Gil-Bazo I, et al. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice[J]. Oncotarget, 2016, 7(19): 28748-28760.
[19] Cazzoli R, Buttitta F, Di Nicola M, et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer[J]. J Thorac Oncol, 2013, 8(9): 1156-1162.
[20] Zhou X, Wen W, Shan X, et al. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis[J]. Oncotarget, 2017, 8(4): 6513-6525.
[21] 王蕾, 欧宗兴. 血清外泌体miR-184在非小细胞肺癌中的表达水平及其诊断效能[J]. 兰州大学学报(医学版), 2018, 44(3): 31-36. WANG Lei, OU Zongxing. Expression and diagnostic efficacy of serum exosome miR-184 in non-small cell lung cancer[J]. Journal of Lanzhou University(Medical Sciences), 2018, 44(3): 31-36.
[22] Cheung TH, Man KN, Yu MY, et a1. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm[J]. Cell Cycle, 2012, 11(15): 2876-2884.
[23] Katada T, Ishiguro H, Kuwabara Y, et al. MicroRNA expression profile in undifferentiated gastric cancer[J]. Int J Oncol, 2009, 34(2): 537-542.
[24] Guo J, Miao Y, Xiao B, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues[J]. J Gastroenterol Hepatol, 2009, 24(4): 652-657.
[25] Jiang Z, Yin J, Fu W, et al. MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC[J]. PLoS One, 2014, 9(4): e94639. doi: 10.1371/journal.pone.0094639.

相关文章 15

[1]	李波波李道堂刘曙光王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[2]	徐平于国放李霞. 不同类型甲状腺上动脉PSV对Graves病与桥本氏甲状腺炎鉴别诊断的价值[J]. 山东大学学报(医学版), 2209, 47(6): 62-64.
[3]	王欣，邢春燕，杨艳平. 血清磷酸丙酮酸水合酶检测对诊断侵袭性白念珠菌感染的临床价值[J]. 山东大学学报(医学版), 2209, 47(6): 92-94.
[4]	秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82.
[5]	查菁,郭婧,左秀丽. 少见类型肠梗阻病因病例报告1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(6): 130-132.
[6]	宋敏,周玉侠,高璐,刘娜,王菊,古晋,张艳萍. 1例6 q三体嵌合胎儿的产前诊断[J]. 山东大学学报 (医学版), 2022, 60(5): 109-113.
[7]	陈兆波,方敏,薛浩然,刘春艳. 去泛素化酶USP35促进非小细胞肺癌细胞迁移和侵袭[J]. 山东大学学报 (医学版), 2022, 60(4): 30-37.
[8]	左立平,蒋丰洋,周斌彬,范金蕾,梁永锋,邓展昊,于德新. 术前MRI在预测169例肝细胞肝癌微血管侵犯及早期复发的价值[J]. 山东大学学报 (医学版), 2022, 60(3): 89-95.
[9]	王静,刘粉,曾荣,黄思源,许长娟,梁子婷,董亮. 以胸膜病变为特征的IgG4相关性肺疾病1例[J]. 山东大学学报 (医学版), 2022, 60(3): 114-116.
[10]	薛美娟,石艳,邵琳琳,王琳,张昀,张阿敏. 遗传性血栓性血小板减少性紫癜1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(3): 121-124.
[11]	张雪,白改改,陶国伟,吴海芳,罗霞,刘培淑. 脐尿管未闭导致膀胱脱垂同时合并脐膨出的罕见病例1例[J]. 山东大学学报 (医学版), 2022, 60(2): 115-117.
[12]	宋钰峰,宁豪,姚志刚,吴海虎,刘非凡,吕家驹. 肾上腺海绵状血管瘤临床及影像特征[J]. 山东大学学报 (医学版), 2022, 60(2): 37-42.
[13]	潘鹏飞,徐立升,纪坤乾,王得翔,李玉. 以呼吸衰竭起病的线粒体肌病1例及文献回顾[J]. 山东大学学报 (医学版), 2022, 60(2): 54-59.
[14]	陈峰,高沛,朱可嘉,丁森泰. 膀胱淋巴上皮瘤样癌1例[J]. 山东大学学报 (医学版), 2022, 60(1): 118-120.
[15]	王传新. 肿瘤液体活检[J]. 山东大学学报 (医学版), 2021, 59(9): 64-71.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed